CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to KPTI

Phase 3

Development Phase

2

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
KPTIPhase 2

Selinexor Phase 2 Est. Readout

Selinexor
Dec 2026~
CT.gov
00%
Sep '26
KPTIPhase 2

Selinexor Phase 2 Est. Readout

Selinexor
Sep 2026~
CT.gov
00%
Development History
Aug '26
KPTIPhase 3
Negative

Selinexor Phase 3 Est. Readout

Selinexor
Aug 2026~
CT.gov
Competitive Landscape

0 competitors in Multiple Myeloma, Refractory

View Full Landscape
Drug Information

Target Indication

Multiple Myeloma, Refractory

Clinical Trial

NCT04414475

Last updated: 12/29/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.